CLARITIN
Pronunciation: lor-AT-a-deen


What it isSecond-generation H1 antagonist; allergic rhinitis and urticaria.
Why this oneCauses less drowsiness than cetirizine, but fexofenadine is generally the least sedating oral option.
What limits itIts low sedation comes with weaker urticaria control than cetirizine; inadequate control often prompts a switch.
Animated chart of estimated U.S. prescriptions per year, H1 antihistamines (1944–2026). Loratadine enters in 1993 (estimated).
Principal riskWeaker than cetirizine in urticaria
Defining liabilityOccasional drowsiness despite low CNS penetration
Read the full label on DailyMed ↗
NO BOXED WARNINGS
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Allergy relief (OTC antihistamine) | Adults & children ≥6 yr | 10 mg (1 tablet) QD | 1 tablet/24 hr |
Renal Undefined
Hepatic Undefined
Available strengths
Pregnancy Undefined
Lactation Undefined
| Strength | #/mo | generic $ | CostPlus | |
|---|---|---|---|---|
| 10 mg | tab | 30 qd | $1.59/mo | offered |
| 10 mg | cap | 30 qd | not offered | |
| 5 mg | chew tab | 30 qd | $15.64/mo | not offered |
| 10 mg | chew tab | 30 qd | not offered | |
| 1 mg/mL | sol | per unit | not offered |
Open Loratadine in the interactive console ↗